Device Trial Radar · NCT02202434
Safety and Efficacy Study of Lotus Valve for Transcatheter Aortic Valve Replacement
Last checked: Nov 20, 2026Latest source record: Dec 17, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
1,425
Actual
Start
Sep 22, 2014
Primary completion
Mar 8, 2017
Study completion May 21, 2021
Sponsor
- Lead sponsor
- Boston Scientific CorporationPublic (BSX)
- Sponsor type
- Industry
- First posted
- Jul 29, 2014
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objective of this study is to evaluate the safety and effectiveness of the Lotus™ Valve System and LOTUS Edge™ Valve System for transcatheter aortic valve replacement (TAVR) in symptomatic subjects with calcific, severe native aortic stenosis who are considered at extreme or high risk for surgical valve replacement.
Conditions
- Aortic Stenosis
Interventions
Lotus Valve SystemDevice
Procedure: Transcatheter aortic valve replacement (TAVR)
CoreValve/Evolut R Transcatheter Aortic Valve Replacement SystemDevice
Procedure: Transcatheter aortic valve replacement (TAVR)
LOTUS Edge Valve SystemDevice
Procedure: Transcatheter aortic valve replacement (TAVR)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants With Events Included in the Primary Safety EndpointTime frame: 30 days following procedure
- Percentage of Participants With Events Included in the Primary Effectiveness EndpointTime frame: 1 year following procedure
Locations
58 sites in 6 countries. Site status is shown where the registry gives one.
Banner Good Samaritan
Phoenix, Arizona
Scottsdale Healthcare - Shea
Scottsdale, Arizona
Scripps Clinic
La Jolla, California
55 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.